24
Feb

Houston biotech DNAtrix has secured a $10.8 million grant to fund clinical development of its oncolytic virus to treat brain cancer, contending with a trove of drugmakers in the promising space.

…read more

Source: DNAtrix bags $10.8M to advance its cancer-killing virus

    

0 No comments